Search Results

There are 8379 results for: content related to: Multidrug resistance-1 gene polymorphisms associated with treatment outcomes in de novo acute myeloid leukemia

  1. You have free access to this content
    Production of P-glycoprotein from the MDR1 upstream promoter is insufficient to affect the response to first-line chemotherapy in advanced breast cancer

    International Journal of Cancer

    Volume 122, Issue 5, 1 March 2008, Pages: 1058–1067, Selina Raguz, Rebecca A. Randle, Eva R. Sharpe, John A. Foekens, Anieta M. Sieuwerts, Marion E. Meijer-van Gelder, Junia V. Melo, Christopher F. Higgins and Ernesto Yagüe

    Version of Record online : 22 OCT 2007, DOI: 10.1002/ijc.23149

  2. MDR1 genotype is associated with hepatic cytochrome P450 3A4 basal and induction phenotype

    Clinical Pharmacology & Therapeutics

    Volume 79, Issue 4, April 2006, Pages: 325–338, Jatinder Lamba, Stephen Strom, Raman Venkataramanan, Kenneth E. Thummel, Yvonne S. Lin, Wei Liu, Cheng Cheng, Vishal Lamba, Paul B. Watkins and Erin Schuetz

    Version of Record online : 16 APR 2006, DOI: 10.1016/j.clpt.2005.11.013

  3. You have free access to this content
    Association of 5′ CpG demethylation and altered chromatin structure in the promoter region with transcriptional activation of the multidrug resistance 1 gene in human cancer cells

    European Journal of Biochemistry

    Volume 262, Issue 3, June 1999, Pages: 924–932, Hitoshi Kusaba, Masaharu Nakayama, Taishi Harada, Minoru Nomoto, Kimitoshi Kohno, Michihiko Kuwano and Morimasa Wada

    Version of Record online : 18 SEP 2003, DOI: 10.1046/j.1432-1327.1999.00469.x

  4. You have full text access to this Open Access content
    Elevated level of lysine 9-acetylated histone H3 at the MDR1 promoter in multidrug-resistant cells

    Cancer Science

    Volume 103, Issue 4, April 2012, Pages: 659–669, Monika Toth, Imre M. Boros and Eva Balint

    Version of Record online : 19 MAR 2012, DOI: 10.1111/j.1349-7006.2012.02215.x

  5. You have free access to this content
    Targeted gene disruption in Candida albicans wild-type strains: the role of the MDR1 gene in fluconazole resistance of clinical Candida albicans isolates

    Molecular Microbiology

    Volume 36, Issue 4, May 2000, Pages: 856–865, Stephanie Wirsching, Sonja Michel and Joachim Morschhäuser

    Version of Record online : 18 JAN 2002, DOI: 10.1046/j.1365-2958.2000.01899.x

  6. MDR1 haplotypes significantly minimize intracellular uptake and transcellular P-gp substrate transport in recombinant LLC-PK1 cells

    Journal of Pharmaceutical Sciences

    Volume 95, Issue 10, October 2006, Pages: 2293–2308, Noha N. Salama, Ziping Yang, Tot Bui and Rodney J.Y. Ho

    Version of Record online : 1 AUG 2006, DOI: 10.1002/jps.20717

  7. No effect of MDR1 C3435T variant on loperamide disposition and central nervous system effects

    Clinical Pharmacology & Therapeutics

    Volume 74, Issue 5, November 2003, Pages: 487–498, Christiane Pauli-Magnus, John Feiner, Claire Brett, Emil Lin and Deanna L. Kroetz

    Version of Record online : 27 NOV 2003, DOI: 10.1016/S0009-9236(03)00234-0

  8. Association between the MDR1 gene variant C3435T and risk of leukaemia: a meta-analysis

    European Journal of Cancer Care

    Volume 22, Issue 5, September 2013, Pages: 617–625, B-B. Zhang, C. Xuan, K-F. Deng, N. Wu and L-M. Lun

    Version of Record online : 3 JUN 2013, DOI: 10.1111/ecc.12067

  9. You have free access to this content
    99mTc-MIBI imaging for prediction of therapeutic effects of second-generation MDR1 inhibitors in malignant brain tumors

    International Journal of Cancer

    Volume 121, Issue 12, 15 December 2007, Pages: 2637–2645, Toshio Sasajima, Naoya Shimada, Yuichiro Naitoh, Masataka Takahashi, Yi Hu, Tomo Satoh and Kazuo Mizoi

    Version of Record online : 20 AUG 2007, DOI: 10.1002/ijc.23011

  10. Polymorphisms in Human MDR1 (P-glycoprotein): Recent Advances and Clinical Relevance

    Clinical Pharmacology & Therapeutics

    Volume 75, Issue 1, January 2004, Pages: 13–33, Catia Marzolini, Erik Paus, Thierry Buclin and Richard B. Kim

    Version of Record online : 22 JAN 2004, DOI: 10.1016/j.clpt.2003.09.012

  11. You have free access to this content
    Effect of MDR1 C3435T polymorphism on cure rates of Helicobacter pylori infection by triple therapy with lansoprazole, amoxicillin and clarithromycin in relation to CYP 2C19 genotypes and 23S rRNA genotypes of H. pylori

    Alimentary Pharmacology & Therapeutics


    Version of Record online : 15 JUN 2007, DOI: 10.1111/j.1365-2036.2007.03408.x

  12. Quantitative determination of MDR1 mRNA expression in peripheral blood lymphocytes: a possible role of genetic polymorphisms in the MDR1 gene

    European Journal of Clinical Investigation

    Volume 33, Issue 3, March 2003, Pages: 261–267, K. Oselin, I. Nowakowski-Gashaw, P. M. Mrozikiewicz, D. Wolbergs, R. Pähkla and I. Roots

    Version of Record online : 14 MAR 2003, DOI: 10.1046/j.1365-2362.2003.01133.x

  13. Effect of itraconazole on the pharmacokinetics and pharmacodynamics of fexofenadine in relation to the MDR1 genetic polymorphism

    Clinical Pharmacology & Therapeutics

    Volume 78, Issue 2, August 2005, Pages: 191–201, Ji-Hong Shon, Young-Ran Yoon, Won-Seok Hong, Phuc Minh Nguyen, Sang-Seop Lee, Young-Gil Choi, In-Jun Cha and Jae-Gook Shin

    Version of Record online : 11 AUG 2005, DOI: 10.1016/j.clpt.2005.04.012

  14. Modulation of multidrug resistance in cancer cells by the E3 ubiquitin ligase seven-in-absentia homologue 1

    The Journal of Pathology

    Volume 214, Issue 4, March 2008, Pages: 508–514, M Liu, R Aneja, H Wang, L Sun, X Dong, L Huo, HC Joshi and J Zhou

    Version of Record online : 17 DEC 2007, DOI: 10.1002/path.2312

  15. You have free access to this content
    Regulation of the MDR1 promoter by E2F1 and EAPP

    FEBS Letters

    Volume 587, Issue 10, May 21, 2013, Pages: 1504–1509, Peter Andorfer and Hans Rotheneder

    Version of Record online : 28 MAR 2013, DOI: 10.1016/j.febslet.2013.03.026

  16. A novel MDR1 G1199T variant alters drug resistance and efflux transport activity of P-glycoprotein in recombinant Hek cells

    Journal of Pharmaceutical Sciences

    Volume 95, Issue 12, December 2006, Pages: 2767–2777, Matthew H. Crouthamel, Daniel Wu, Ziping Yang and Rodney J.Y. Ho

    Version of Record online : 17 AUG 2006, DOI: 10.1002/jps.20743

  17. You have free access to this content
    Alu-associated interstitial deletions and chromosomal re-arrangement in 2 human multidrug-resistant cell lines

    International Journal of Cancer

    Volume 86, Issue 4, 15 May 2000, Pages: 506–511, Taishi Harada, Jun Nagayama, Kimitoshi Kohno, Lyn A. Mickley, Tito Fojo, Michihiko Kuwano and Morimasa Wada

    Version of Record online : 26 APR 2000, DOI: 10.1002/(SICI)1097-0215(20000515)86:4<506::AID-IJC10>3.0.CO;2-8

  18. You have free access to this content
    Trps1 is associated with the multidrug resistance of osteosarcoma by regulating MDR1 gene expression

    FEBS Letters

    Volume 588, Issue 5, March 03, 2014, Pages: 801–810, Ming Jia, Jing Hu, Weiwei Li, Peng Su, Hui Zhang, Xiaofang Zhang and Gengyin Zhou

    Version of Record online : 31 JAN 2014, DOI: 10.1016/j.febslet.2014.01.041

  19. You have free access to this content
    Hyperthermia for treatment of rectal cancer: Evaluation for induction of multidrug resistance gene (mdr1) expression

    International Journal of Cancer

    Volume 80, Issue 1, 5 January 1999, Pages: 5–12, Ulrike Stein, Beate Rau, Peter Wust, Wolfgang Walther and Peter M. Schlag

    Version of Record online : 8 NOV 1999, DOI: 10.1002/(SICI)1097-0215(19990105)80:1<5::AID-IJC2>3.0.CO;2-F

  20. Determination of MDR1 gene expression for prediction of chemotherapy tolerance and treatment outcome in dogs with lymphoma

    Veterinary and Comparative Oncology

    Volume 13, Issue 4, December 2015, Pages: 363–372, I. Gramer, M. Kessler and J. Geyer

    Version of Record online : 3 JUL 2013, DOI: 10.1111/vco.12051